美银下调诺瓦瓦克斯医药目标价至7美元 聚看点

Group 1 - Bank of America has lowered the target price for Novavax from $9 to $7, changing its rating from "Neutral" to "Underperform" [2] - Citigroup has initiated coverage on Novavax with a "Sell" rating and a target price of $6 [2]